Patient Access to Rencell in China Case Solution
Abstract:
Rencell is a targeted treatment versus metastatic kidney cell cancer, which considerably extends disease-free survival. Rencell's worldwide wholesale cost of $1,000 for one month of treatment makes the drug unaffordable for lots of clients in China. What prices method should Axios International, a health care consultancy, advise to Paracelsus, the big biopharmaceutical business which markets Rencell?
Pedagogical Goals:
Rates technique for a life-prolonging medication in a nation where couple of clients can manage to pay the global cost. Secret principles: - capability to pay, price - market access - rate discrimination, separated rates - business social duty
This is just an excerpt. This case is about Marketing
published: 24 Jun 2013
Related Case Solutions & Analyses:
Wyoff and China-LuQuan: Negotiating a Joint Venture (B)
DuPont-NASCAR Marketing
Xiameter: The Past and Future of a Disruptive Innovation
Mountain Equipment Co-op: Digital Strategy
Parkin Laboratories: Sales Target Dilemma
Telenor’s Dilemma: The 2G Spectrum Scam in India
Targeting College Students on Facebook? How to Stop Wasting Your Money
Nestle, Portuguese Version
Callaway Golf Canada: The Mobile Performance Team
Monsanto Europe: Monsanto Introduces GMOs to Europe with Unexpected Results
